Genmab — Juni 2020
-
the “deep responses” seen from teclistamab suggest an antibody-based approach could produce results that improve on existing standards set by Janssen’s Darzalex (daratumumab). https://pharmaphorum.com/views-analysis-oncology/asco-2020-round-up-virtual-conference-still-delivers-the-drama/
-
-
-
Jeg finder ikke mange analyser og kommentarer på de jobtal i finansmedierne.
-
Jeg lægger begge links i aktiesnakken.
-
-
God morgen.
-
AstraZeneca Approaches Gilead About Potential Merger: https://www.bloomberg.com/news/articles/2020-06-07/astrazeneca-is-said-to-approach-gilead-about-potential-merger?sref=UqeAE4Bb
-
Martin Hutchings kommentar om epcoritamab på Twitter https://twitter.com/dochutchings/status/1269574646501969921?s=21
-
-
Epcoritamab kommentar fra Pranay kapoor https://twitter.com/pranay_kapoor20/status/1269628104802066432?s=21
-
PS Martin Hutchings er læge på rigshospitalet , og er medvirkende i epcoritamab studiet
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind